Hydrochloric Acid

Hydrochloric Acid

SCHEMBL1074261

CC(=O)c1cccc(C(C)=O)n1.CC1=CCC(=N)C(C)=C1.CC1=CCC(=N)C(C)=C1.[Cl-].[Cl-].[Fe+2]

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.36
CYP1A2 P05177 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
ACMSD Q8TDX5 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL1071221 0.97 ALDH1A1 (0.36) ALDH1A1CYP1A2KDM4EALOX15TSHR
Hydrochloric Acid SCHEMBL28930333 0.74 ALDH1A1 (0.58) ALDH1A1CYP1A2KDM4EALOX15TSHR
Hydrochloric Acid SCHEMBL1071433 0.74 ALDH1A1 (0.35) ALDH1A1CYP1A2KDM4EALOX15TSHR
SCHEMBL30924435 0.73
SCHEMBL30924436 0.73
Hydrochloric Acid SCHEMBL1071457 0.71 ALDH1A1 (0.35) ALDH1A1CYP1A2KDM4EALOX15TSHR
SCHEMBL455687 0.71 KDM4E (0.59) ALDH1A1CYP1A2KDM4EALOX15TSHR
SCHEMBL5176456 0.69 CYP1A2 (0.33) ALDH1A1CYP1A2KDM4EALOX15TSHR
SCHEMBL3875700 0.69 CYP1A2 (0.33) ALDH1A1CYP1A2KDM4EALOX15TSHR
Hydrochloric Acid SCHEMBL27613793 0.69 KDM4E (0.56) ALDH1A1CYP1A2KDM4EALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1824888-B1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2017-01-18 EP disclosed
EP-1740626-B1 CATALYST SYSTEM FOR OLEFIN POLYMERIZATION, ITS PRODUCTION AND USE BASELL POLYOLEFINE GMBH (DE) 2014-10-22 EP disclosed
EP-2459600-B1 ORGANOMETALLIC TRANSITION METAL COMPOUND, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS BASELL POLYOLEFINE GMBH (DE) 2013-11-20 EP disclosed
US-8471050-B2 Organometallic transition metal compound, catalyst system and preparation of polyolefins BASELL POLYOLEFINE GMBH (DE) 2013-06-25 US disclosed
US-20120142874-A1 Organometallic Transition Metal Compound, Catalyst System and Preparation of Polyolefins BASELL POLYOLEFINE GMBH (DE) 2012-06-07 US disclosed
EP-2459600-A1 ORGANOMETALLIC TRANSITION METAL COMPOUND, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS Basell Polyolefine GmbH (DE) 2012-06-06 EP disclosed
US-7973114-B2 Monocyclopentadienyl complexes BASELL POLYOLEFINE GMBH (DE) 2011-07-05 US disclosed
WO-2011012245-A1 ORGANOMETALLIC TRANSITION METAL COMPOUND, CATALYST SYSTEM AND PREPARATION OF POLYOLEFINS BASELL POLYOLEFINE GMBH (DE) 2011-02-03 WO disclosed
EP-1861409-B1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2011-01-19 EP disclosed
US-7834112-B2 Method of polymerization of olefins BASELL POLYOLEFINE GMBH (DE) 2010-11-16 US disclosed
WO-2004104052-A1 TRANSITION-METAL COMPLEXES WITH TRIDENTATE, NITROGEN-CONTAINING LIGANDS BASELL POLYOLEFINE GMBH (DE) 2004-12-02 WO disclosed
US-6787499-B2 Catalyst for the production of α-olefin and α-olefin production method IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2004-09-07 US disclosed
WO-2004056481-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-07-08 WO disclosed
WO-2004056482-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-07-08 WO disclosed
WO-2004020479-A2 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-03-11 WO disclosed
WO-2004018489-A1 MONOCYCLOPENTADIENYL COMPLEXES BASELL POLYOLEFINE GMBH (DE) 2004-03-04 WO disclosed
US-20030134991-A1 Catalyst for the production of alpha-olefin and alpha-olefin production method thereof IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2003-07-17 US disclosed
US-6555633-B1 A alpha-olefin oligomerization catalyst obtained by contacting (a) a clay, clay mineral or ion-exchange layer compound with (b-1) a transition metal complex of group 4 to 6 of periodic table, and (a) is treated with organosilane compound IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2003-04-29 US disclosed
EP-1106249-A1 CATALYST FOR $g(a)-OLEFIN PRODUCTION AND PROCESS FOR PRODUCING $g(a)-OLEFIN IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2001-06-13 EP disclosed
EP-1066877-A1 CATALYSTS FOR $g(a)-OLEFIN PRODUCTION AND PROCESSES FOR PRODUCING $g(a)-OLEFIN IDEMITSU PETROCHEMICAL CO., LTD. (JP) 2001-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142874-A1 Organometallic Transition Metal Compound, Catalyst System and Preparation of Polyolefins PRMT9, INTS9, ACAD9 ALDH1A1 2207/4885CYP1A2 956/4885KDM4E 2206/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.